On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of ...

Engineered CAR‑T cells suppressed HIV off medication in two people — promising but early. Larger trials are needed.

Three people were able to suppress the virus for months without their usual treatment regimen.

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

Antiretroviral therapy dynamics encompass the complex interplay between drug regimens, viral kinetics and host immune responses in the management of HIV infection. Since the introduction of ...

ACC017 showed significant reductions in HIV-RNA levels in ART-naïve patients, with no viral breakthrough or adverse events reported. The safety profile of ACC017 was comparable to placebo, with no ...

Antiretroviral therapy (ART) has transformed HIV from a fatal condition into a manageable chronic disease, yet equitable access and the prevention of drug resistance remain pressing global challenges.

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...

Background: Current guidelines for the use of antiretroviral (ARV) therapy during pregnancy recommend that women be offered treatment with combination ARV therapy used in nonpregnant HIV-infected ...